Serum levels of the advanced glycation end products Nepsilon-carboxymethyllysine and pentosidine are not influenced by treatment with the angiotensin receptor II type 1 blocker irbesartan in patients with type 2 diabetic nephropathy and hypertension.
NEPHRON CLINICAL PRACTICE（2008）
Key words
advanced glycation end products,angiotensin II type 1 blockers,irbesartan,diabetic nephropathy,N-epsilon-carboxymethyllysine,pentosidine
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined